Marlyn J Mayo

Summary

Affiliation: University of Texas Southwestern Medical Center
Country: USA

Publications

  1. doi request reprint Cholestatic liver disease overlap syndromes
    Marlyn J Mayo
    Department of Internal Medicine, Division of Digestive and Liver Diseases, UT Southwestern, 5323 Harry Hines Boulevard, Dallas, TX 75390 9151, USA Electronic address
    Clin Liver Dis 17:243-53. 2013
  2. doi request reprint Management of autoimmune hepatitis
    Marlyn J Mayo
    University of Texas Southwestern Medical Center, Dallas, Texas 75390 911, USA
    Curr Opin Gastroenterol 27:224-30. 2011
  3. pmc Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay
    Marlyn J Mayo
    University of Texas Southwestern Medical Center, Dallas, TX 75390 9151, USA
    Hepatology 48:1549-57. 2008
  4. doi request reprint Natural history of primary biliary cirrhosis
    Marlyn J Mayo
    Department of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390 9151, USA
    Clin Liver Dis 12:277-88; viii. 2008
  5. ncbi request reprint Sertraline as a first-line treatment for cholestatic pruritus
    Marlyn J Mayo
    Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 9151, USA
    Hepatology 45:666-74. 2007
  6. ncbi request reprint The relationship between hepatic immunoglobulin production and CD154 expression in chronic liver diseases
    Marlyn J Mayo
    Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 9151, USA
    Liver Int 26:187-96. 2006
  7. ncbi request reprint Patients and patience: the pitfalls of primary biliary cirrhosis trials
    Marlyn J Mayo
    Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    Nat Clin Pract Gastroenterol Hepatol 2:552-3. 2005
  8. ncbi request reprint Primary biliary cirrhosis: the future
    Marlyn J Mayo
    Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Room F 4 120, Dallas, TX 75390, USA
    Clin Liver Dis 7:957-69. 2003
  9. ncbi request reprint Extrahepatic manifestations of hepatitis C infection
    Marlyn J Mayo
    Department of Internal Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medial Center at Dallas, Dallas, Texas 75390 9151, USA
    Am J Med Sci 325:135-48. 2003
  10. ncbi request reprint Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis
    Burton Combes
    The University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 9151, USA
    Hepatology 42:1184-93. 2005

Research Grants

Collaborators

Detail Information

Publications12

  1. doi request reprint Cholestatic liver disease overlap syndromes
    Marlyn J Mayo
    Department of Internal Medicine, Division of Digestive and Liver Diseases, UT Southwestern, 5323 Harry Hines Boulevard, Dallas, TX 75390 9151, USA Electronic address
    Clin Liver Dis 17:243-53. 2013
    ..Drug-induced liver injury and IgG4 disease may masquerade as autoimmune hepatitis or primary sclerosing cholangitis and are important to consider in the differential diagnosis of the overlap or variant syndromes...
  2. doi request reprint Management of autoimmune hepatitis
    Marlyn J Mayo
    University of Texas Southwestern Medical Center, Dallas, Texas 75390 911, USA
    Curr Opin Gastroenterol 27:224-30. 2011
    ..Fortunately, clinical research in the treatment of AIH has experienced a renaissance in the 21st century...
  3. pmc Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay
    Marlyn J Mayo
    University of Texas Southwestern Medical Center, Dallas, TX 75390 9151, USA
    Hepatology 48:1549-57. 2008
    ..However, at earlier times in the disease process (4 and 6 years before the first event), the prognostic performance of ELF was significantly better than MELD or Mayo R score...
  4. doi request reprint Natural history of primary biliary cirrhosis
    Marlyn J Mayo
    Department of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390 9151, USA
    Clin Liver Dis 12:277-88; viii. 2008
    ..A need remains to better define and predict the course of symptomatic and asymptomatic patients on and off UDCA in order to better evaluate outcomes of clinical trials...
  5. ncbi request reprint Sertraline as a first-line treatment for cholestatic pruritus
    Marlyn J Mayo
    Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 9151, USA
    Hepatology 45:666-74. 2007
    ..CONCLUSION: Sertraline seems to be an effective, well-tolerated treatment for pruritus due to chronic liver disease. These results suggest that serotonergic pathways are important in the perception of itch...
  6. ncbi request reprint The relationship between hepatic immunoglobulin production and CD154 expression in chronic liver diseases
    Marlyn J Mayo
    Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 9151, USA
    Liver Int 26:187-96. 2006
    ..CD154 is a member of the tumor necrosis factor superfamily, which is primarily expressed by activated T cells...
  7. ncbi request reprint Patients and patience: the pitfalls of primary biliary cirrhosis trials
    Marlyn J Mayo
    Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    Nat Clin Pract Gastroenterol Hepatol 2:552-3. 2005
  8. ncbi request reprint Primary biliary cirrhosis: the future
    Marlyn J Mayo
    Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Room F 4 120, Dallas, TX 75390, USA
    Clin Liver Dis 7:957-69. 2003
    ..In addition, the ability to isolate and culture human biliary epithelial cells greatly facilitates in vitro studies. With the advent of these tools, investigators are well poised to address the important issues of PBC in the future...
  9. ncbi request reprint Extrahepatic manifestations of hepatitis C infection
    Marlyn J Mayo
    Department of Internal Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medial Center at Dallas, Dallas, Texas 75390 9151, USA
    Am J Med Sci 325:135-48. 2003
    ....
  10. ncbi request reprint Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis
    Burton Combes
    The University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 9151, USA
    Hepatology 42:1184-93. 2005
    ..In conclusion, methotrexate when added to UDCA for a median period of 7.6 years had no effect on the course of PBC treated with UDCA alone...
  11. ncbi request reprint Long-term efficacy of sertraline as a treatment for cholestatic pruritus in patients with primary biliary cirrhosis
    Jeff Browning
    Division of Digestive and Liver Diseases, Department of Internal Medicine, The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390 9151, USA
    Am J Gastroenterol 98:2736-41. 2003
    ....
  12. ncbi request reprint Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment
    Carlo Selmi
    Division of Rheumatology, Allergy, and Clinical Immunology, University of California at Davis, 95616, USA
    Gastroenterology 127:485-92. 2004
    ..Accordingly, we evaluated the concordance of PBC in a genetically defined population of twin sets and evaluated the clinical characteristics between concordant subjects...

Research Grants3

  1. ROLE OF CD40-CD40 LIGAND IN PRIMARY BILIARY CIRRHOSIS
    MARLYN MAYO; Fiscal Year: 2003
    ..These studies will provide insight into the role of T cells in the pathogenesis of PBC and provide information useful in developing new treatment modalities. ..
  2. 1Treatment of Cholestatic Pruritus With Sertraline
    MARLYN MAYO; Fiscal Year: 2004
    ..These studies will serve as pilot trials. The results of this proposed project will be used to design a larger controlled trial that could be proposed for funding through an R01 mechanism. ..
  3. Longitudinal Studies of Primary Biliary Cirrhosis
    MARLYN MAYO; Fiscal Year: 2006
    ..In addition, the correlation between each of the putative surrogate markers will be analyzed. The results of this analysis will then be used to design future clinical trials in the field of PBC. ..